Carter Bankshares, Inc. Announces Second Quarter 2026 Financial Results

Carter Bankshares (NASDAQ:CARE) reported Q2 2026 net income of $28.9M, or $1.31 diluted EPS, versus $85.8M in Q1 2026 and $8.5M in Q2 2025. Net interest income was $40.0M and net interest margin rose to 3.38%. The company completed the Bearing Insurance Group sale, recognizing a $35.9M pre-tax gain, and repositioned securities, booking a $12.5M pre-tax loss.

Original reporting
Published Jul 23, 2026, 12:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 12:49 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CARE
Neutral
medium confidence
Mentioned
$CARE
Relevance
6/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$CARENeutralMed
01

Why it matters

The insurance transaction generated a large pre-tax gain and tangible book value accretion, while the portfolio repositioning produced a pre-tax loss but shifted the portfolio toward higher-yield AAA/AA securities. Credit quality worsened sequentially with NPLs and NPA ratios rising, though allowance coverage improved versus nonperforming loans.

02

Market read

Traders can update expectations for CARE’s earnings quality (nonrecurring vs recurring), balance-sheet yield profile, and near-term credit risk given the sequential NPL/NPA deterioration.

03

What to watch

Investors may focus on the sustainability of the NIM expansion and whether the higher NPLs (including the downgraded C&I loans) could drive future provision expense, offsetting the expected benefit from higher-yield AAA/AA securities.

Relevance 6/10Novelty 6/10Timing: post-market results release, investors digesting Q2 2026 print and transaction impacts

Background

Carter Bankshares (NASDAQ: CARE) reported Q2 2026 financial results and tied performance to completed nonrecurring transactions in 1H 2026, including the Bearing Insurance Group sale and a loan sale, plus a second-quarter AFS securities repositioning.

Company-level read

Ticker impact

$CARENeutralMedium confidence
Context

Carter Bankshares reported Q2 2026 results and disclosed a Bearing Insurance Group sale plus a securities portfolio repositioning with a pre-tax loss.

Expected impact

Near-term trading likely hinges on whether investors view the nonrecurring gains as repeatable versus the repositioning as a durable earnings tailwind.

Evidence & confidence

The article provides detailed quarter and six-month income, NIM expansion, credit-quality changes, and explicit transaction impacts (EPS accretion, tangible book value increase, and repositioning loss/expected benefit). However, it does not provide forward guidance beyond the expectation of improved future earnings performance.

Market effects

Regional bank investors may reprice the balance-sheet management tradeoff between realizing gains from asset sales and taking mark-to-market losses to reposition AFS securities.

Limited, primarily relevant to US regional banking sentiment and credit-quality expectations rather than a broad macro read-across.

Low, as the disclosure is company-specific and not tied to global rates or cross-border exposures.

Counterpoint

The headline net income decline versus Q1 may mask that core operating strength is being supported by one-time transaction gains, while credit quality deteriorated sequentially (NPLs and NPA ratios up).

Key entities

  • Carter Bankshares, Inc.

    Holding company reporting Q2 2026 net income, NIM, credit metrics, and transaction impacts.

  • Bearing Insurance Group, LLC

    Company whose membership interest sale generated a recognized pre-tax net gain and EPS/tangible book accretion.

  • Loan Sale Transaction

    First-quarter 2026 sale of a large nonperforming credit relationship that reduced NPLs year-over-year.

  • Portfolio Repositioning

    Second-quarter AFS securities repositioning: sold lower-yield securities and bought higher-yield AAA/AA securities, with a pre-tax loss and expected future earnings improvement.

Related articles

$CAREMed

Carter Bankshares, Inc. (CARE): Results of Operations and Financial Condition

Carter Bankshares, Inc. (CARE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 care-2q26_ex991xer.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE – July 23, 2026 Carter Bankshares, Inc. Announces Second Quarter 2026 Financial Results Martinsville, VA, July 23, 2026 – Carter Bankshares, Inc. (the “Company”) (NASDAQ:CARE), the holding compan

$MNDYHighAI 8/10

Why Monday.com Stock Popped in August

Monday.com (MNDY) stock rose 16% in August, despite initial investor concerns over its Q2 results. Revenue grew 22% YoY to $365M, and adjusted net income increased 13% to $65.6M. The company provided optimistic guidance for Q3 and 2026. A strong earnings report from Salesforce later in the month boosted investor sentiment in the CRM sector, benefiting Monday.com.

$AQSTMed

Aquestive Therapeutics (AQST): Second Chance At Anaphylm Comes Into Focus

Aquestive Therapeutics (AQST) reported Q2 2026 results, staying on track to resubmit Anaphylm epinephrine film to the FDA in Q3 2026. Studies addressed FDA concerns, with improved packaging and labeling. Revenue rose 38% to $13.8M, but net loss widened to $22.9M. Cash reserves stand at $98.5M. The company also advanced its epinephrine prodrug platform and manufacturing business.

$CRMDMedAI 8/10

CorMedix (CRMD) Just Tripled Its Profits, But Guidance Barely Budged

CorMedix (CRMD) reported Q2 revenue of $101.9M, up from $39.7M a year ago, with net income of $26M. Management raised adjusted EBITDA guidance but kept full-year revenue guidance unchanged. DefenCath and the Melinta portfolio drove growth, with new supply agreements signed. The company expects to submit an sNDA for REZZAYO in Q3. Operating expenses increased due to Melinta's costs and R&D spending. Hedge fund ownership rose, while short interest remained high at 22.30%.

$CCSIMed

Consensus Cloud’s (CCSI) Buyback Doubles, But Growth Has A Catch

Consensus Cloud Solutions (CCSI) reported Q2 revenue of $91.4M, up 4.1%, and net income of $27.4M, up 31.7%. The board doubled its buyback authorization to $200M. Corporate segment revenue rose 9.3%, while the SoHo business declined 4.7%. Adjusted EBITDA was flat at $48.3M. The company reaffirmed its 2026 guidance and issued steady Q3 guidance.